Dr. Lydia Eshak Mikhael, BPharm, MSc is a pharmaceutical professional with more than a decade of experience in clinical pharmacy, regulatory affairs, and clinical research management. She currently serves as Director of Regulatory Affairs and Clinical Trials Management at CRK Clinical Research Key (CRO) in Kenya, where she oversees regulatory strategy, clinical trial coordination, and compliance with international research standards including ICH-GCP.
She previously worked with the Egyptian Drug Authority, where she contributed to the evaluation and registration of pharmaceutical products and supported clinical pharmacy programs implemented across multiple hospitals in Egypt.
Dr. Mikhael holds a Master of Business Administration (MBA) in Strategic Management from the Arab Academy for Science, Technology and Maritime Transport and a Bachelor of Pharmacy from Ahram Canadian University.
Her experience spans regulatory science, drug information, clinical pharmacy services, and healthcare procurement, giving her a multidisciplinary perspective on healthcare systems, research implementation, and regulatory compliance.
Through her work with Amyloidosis Africa, she supports the development of ethically conducted research collaborations and initiatives aimed at improving awareness and diagnosis of cardiac amyloidosis in African healthcare settings.
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.